Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer

Clinical trial NCT00486954 · COMPLETED

Trial details

NCT number: NCT00486954
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neoplasms, Gastrointestinal Tract

Start date: 2007-07-01
Primary completion: 2012-01-01
Enrollment: 273

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.